INmune Bio Inc (INMB) financials · $33.5M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
INmune Bio Inc (INMB) $33.5M cap.
| Line | Q2 2026 | Q1 2026 |
|---|---|---|
| Operating Income | -$1.48M | -$5.81M |
| Net Income | -$1.27M | -$5.41M |
| EPS (Diluted) | -$0.05 | -$0.20 |
| Line | Q2 2026 | Q1 2026 |
|---|---|---|
| Total Assets | $26.8M | $25.8M |
| Current Assets | $23.8M | $22.8M |
| PP&E | $1.26M | $903.0K |
| Total Liabilities | $6.48M | $6.19M |
| Current Liabilities | $5.89M | $5.39M |
| Shareholders' Equity | $20.4M | $19.6M |
| Retained Earnings | -$215.7M | -$214.4M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$22.6M | -$33.4M |
| CapEx | $1.04M | N/A |
| Investing Cash Flow | -$1.04M | N/A |
| Financing Cash Flow | $27.6M | $18.2M |
| Net Change in Cash | $3.83M | -$14.9M |
| Free Cash Flow | -$23.6M | N/A |
FAQ
What is INMB P/E and revenue?
INmune Bio Inc (INMB) $33.5M cap.
What is INMB revenue?
INMB income-statement cache has no revenue figure yet.
Is INMB profitable?
INmune Bio Inc last cached net income is -$1.27M (Q2 2026).
What are INMB total assets?
INmune Bio Inc last cached total assets are $26.8M (Q2 2026).
What is INMB free cash flow?
INmune Bio Inc last cached free cash flow is -$23.6M (FY2025).
Not investment advice. Cached statements, not a live tape.